The Antivirals Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions - Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2011-2022) and extends its insights into a ten-year forecast period (2024-2033).
Learn More On The Antivirals Market:
https://www.thebusinessresearchcompany.com/report/antivirals-global-market-report
According to The Business Research Company’s Antivirals Global Market Report
2024, The antivirals market size has grown strongly in recent years. It will
grow from $97.72 billion in 2023 to $105.73 billion in 2024 at a compound
annual growth rate (CAGR) of 8.2%.
The growth in the historic period
can be attributed to viral disease prevalence, public health concerns, patent
expirations, government initiatives.
The antivirals market size is expected to see strong growth in the next few
years. It will grow to $143.83 billion in 2028 at a compound annual growth rate
(CAGR) of 8.0%. The growth in the
forecast period can be attributed to emerging viral threats, global health
initiatives. Major trends in the forecast period include technological
advances, telemedicine and digital health, personalized medicine.
The increasing incidence of influenza is anticipated to propel the growth of
the antiviral market going forward. Influenza, also called flu, is a highly
contagious viral respiratory infection caused by influenza viruses that affect
the nose, throat, and lungs. Antivirals are used for the treatment of influenza
and are designed to inhibit the replication and spread of influenza viruses
within the body. For instance, in October 2022, according to the Centers for
Disease Control and Prevention, a US-based health agency, during 2021-2022
season, there were 9 million flu illnesses, 4 million flu-related medical
visits, 100,000 flu-related hospitalizations, and 5,000 flu deaths. Therefore,
the increasing incidence of influenza is driving the growth of the antiviral
market.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample_request?id=2437&type=smp
The antivirals market covered in this report is segmented –
1) By Type: Branded; Generic
2) By Drug Class: DNA Polymerase Inhibitors; Reverse Transcriptase Inhibitors;
Protease Inhibitors; Neuraminidase Inhibitors; Other Drug classes
3) By Application: HIV; Hepatitis; Herpes; Influenza; Other Applications
The antivirals market report table of contents includes:
1. Executive Summary
2.
Antivirals Market Characteristics
3.
Antivirals Market Trends And Strategies
4.
Antivirals Market - Macro Economic Scenario
5. Global
Antivirals Market Size and Growth
.
31. Global Antivirals Market Competitive Benchmarking
32. Global
Antivirals Market Competitive Dashboard
33. Key
Mergers And Acquisitions In The Antivirals Market
34.
Antivirals Market Future Outlook and Potential Analysis
35.
Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
No comments:
Post a Comment